Zevra Therapeutics ZVRA
NASDAQ ZVRA
$11.85 -0.07 (-0.59%)
At close: Nov 11, 2026 · 4:00 PM EST

Zevra Therapeutics (ZVRA) Change in Intangibles (2026)

Updated

Zevra Therapeutics' Change in Intangibles came in at -$5 million for Q2 2026.

Analysis

Zevra Therapeutics (ZVRA) Change in Intangibles (2026) Analysis & Trends

For FY2024, Zevra Therapeutics' Change in Intangibles was $6 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Intangibless (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.06 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 995.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -7.20 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Zevra Therapeutics 708.52 Mn -100.24 Mn 36.01 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -5.00 Mn
Mar 31, 2026 -43.94 Mn
API Access

Zevra Therapeutics Change in Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-intangibles&ticker=ZVRA&period=max&api_key=YOUR_API_KEY